Proton beam irradiation for the treatment of uveal melanoma

Article Sidebar

Computer-generated three-dimensional model of a the eye with a tumor.
PDF
Published: Apr 30, 1997
Keywords:
uveal melanoma

Main Article Content

Paul Gaudio, BSL
Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School
Michael Tolentino, MD
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Evangelos S. Gragoudas, MD
Massachusetts Eye and Ear Infirmary, Harvard Medical School

Abstract

Objective
To review the history, process and prognosis associated with proton beam irradiation for the treatment of uveal melanoma.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Gaudio P, Tolentino M, Gragoudas ES. Proton beam irradiation for the treatment of uveal melanoma. Digit J Ophthalmol. 1997;3(2). Accessed May 2, 2026. https://djo.harvard.edu/index.php/djo/article/view/930
Issue
Vol. 3 No. 2 (1997)
Section
Original Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

Wyngaarden JB, Smith LH, eds. Cecil Textbook of Medicine, 18th ed., Vol I. Philadelphia, WB Saunders Co., 1988, p. 1115.

Constable IJ, Koehler AM. Experimental ocular irradiation with accelerated protons. Invest Ophthalmol 1974;113:280-7.

Gragoudas ES, Goitein M, Verhey L, Munzenrider JE, Suit H, Koehler A. Proton beam irradiation, an alternative to enucleation for intraocular melanomas. Ophthalmol 1980;87:571-80.

Gragoudas ES, Goitein M, Koehler AM, et al. Proton irradiation of choroidal melanomas, preliminary results. Arch Ophthalmol 1978;96:1583-91.

Wilson RR. Radiological use of fast protons. RADIOL 1946;47:547.

Gragoudas ES, Goitein M, Koehler AM, et al. Proton irradiation of small choroidal malignant melanomas. Am J Ophthalmol 1977;83:665-73.

Reese AB, Merriam GR, Martin HE. Treatment of bilateral retinoblastoma by irradiation and surgery; report on 15 year results. Am J Ophthalmol 1949;32:175-80.

Hultberg S, Walstam R, Asard PE. Two special applications of high-energy electron beams. Acta Radiol 1965;3:287-90.

Long RS, Balin MA, Rotman M. Conservative treatment of intra-ocular melanomas. Trans Am Acad Ophthalmol Otolaryngol 1971.75:84-93.

Newman GH, Davidorf FH, Havener WH, et al. Conservative management of malignant melanoma: I. Irradiation as a method of treatment for malignant melanoma of the choroid. Arch Ophthalmol 1970;83:21-26.

Lommatzsch PK. Experiences in the treatment of malignant melanoma of the choroid with 106Ru-106Ru beta ray applicators. Trans Ophthalmol Soc UK 1973;93:119-32.

Reese AB, Ellsworth RM. Management of retinoblastoma. Ann NY Acad Sci 1964;114:958-63.

Bedford MA, Bedotto C, Macfaul PA. Radiation retinopathy after the application of a cobalt plaque: report of three cases. Br J Ophthalmol 1970;54:505-9.

Macfaul PA, Bedford MA. Ocular complications after therapeutic irradiation. Br J Ophthalmol 1970;54:237-47.

Kjellberg RN, Shintani A, Frantz AG, et al. Proton-beam therapy in acromegaly. N Engl J Med 1969;287:689-96.

Falkner S, Fors B, Larsson B. Pilot study on proton irradiation of human carcinoma. Acta Radiol 1962;58:33-40.

Constable IJ, Koehler AM, Schmidt RA. Proton irradiation of simulated ocular tumors. Invest Ophthalmol 1975;14:547-55.

Gragoudas ES, Zakov NZ, Albert DM, Constable IJ. Long-term observations of proton-irradiated monkey eyes. Arch Ophthalmol 1979;97: 2184-91.

Gragoudas ES, Goitein M, Verhey L, et al. Proton beam irradiation of uveal melanomas, results of a 5 1/2 year study. Arch Ophthalmol 1982;100:928-34.

Gragoudas ES, Seddon J, Goitein M, et al. Current results of proton beam irradiation of uveal melanomas. Ophthalmol 1985;92:284-91.

Gragoudas ES, Goitein M, Koehler A, et al. Proton irradiation of malignant melanoma of the ciliary body. Br J Ophthalmol 1979;63:135-9.

Gragoudas ES, Seddon JM, Egan KM, et al. Long-term results of proton beam irradiated uveal melanomas. Ophthalmol 1987;94:349-53.

Gragoudas ES, Egan KM, Seddon JM, Walsh SM. Munzenrider JE. Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmol 1992;99:760-6.

Zografos L, Gailloud CL, Perret CH, et al. Rapport sur le traitement conservateur des melanomes de l’uvee a la clinique ophthalmologique universitaire de Lausanne. Klin Monatsbl Augenheilkd 1988;192:572-8.

Brovkina AF, Zarubei GD. Ciliochoroidal melanomas treated with a narrow medical proton beam. Arch Ophthalmol 1986;104:402-4.

Gragoudas ES. Current approaches in the management of uveal melanomas. Int Ophthalmol Clin 1992;32:129-38.

Seddon JM, Gragoudas ES, Polivogianis L, et al. Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmol 1986;93:666-74.

Seddon JM, Gragoudas ES, Egan KM, et al. Uveal melanomas near the optic disc or fovea, visual results after proton beam irradiation. Ophthalmol 1987;94:354-61.

Park SS, Walsh SM, Gragoudas ES. Visual-field deficits associated with proton beam irradiation for parapillary choroidal melanoma. Ophthalmol 1996;103:110-6.

Gragoudas ES, Egan K, Walsh SM, Regan S, Munzenrider JE, Taratuta V. Lens changes after proton beam irradiation for uveal melanoma. Am J Ophthalmol 1995;119:157-64.

Cogan DC, Donaldson DD, Reese AB. Clinical and pathological characteristics of radiation cataract. Arch Ophthalmol 1952;47:55-70.

Egan KM, Gragoudas ES, Seddon JM, et al. The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmol 1989;96:1377-83.

Gragoudas ES, Seddon JM, Egan KM, et al. Metastasis from uveal melanoma after proton beam irradiation. Ophthalmol 1988;95:992-9.

Gragoudas ES, Seddon JM, Egan KM, et al. Prognostic factors for metastasis following proton beam irradiation of uveal melanomas. Ophthalmol 1986;93:665-80.

Egan KM, Walsh SM, Seddon JM, Gragoudas ES. An evaluation of the influence of reproductive factors on the risk of metastasis from uveal melanoma. Ophthalmol 1993;100:1160-5.

Gragoudas ES, Egan KM, Seddon JM, et al. Survival of patients with metastasis from uveal melanoma. Ophthalmol 1991;98:383-90.

Seddon JM, Gragoudas ES, Egan KM, et al. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmol 1990;97:769-77.

MacLean IW. Discussion of: Relative survival rates after alternative therapies for uveal melanoma. Ophthalmol 1990;97:777.

Seddon JM, Gragoudas ES, Albert DM. Ciliary body and choroidal melanomas treated by proton beam irradiation, histopathologic study of eyes. Arch Ophthalmol 1983;101:1402-8.

Zinn KM, Stein/Pokorny K, Jakobiec FA, et al. Proton beam irradiated epithelioid cell melanoma of the ciliary body. Ophthalmol 1981;88:1315-21.

Ferry AP, Blair DJ, Gragoudas ES, Volk SC. Pathologic examination of ciliary body melanoma treated with proton beam irradiation. Arch Ophthalmol 1985;103:1849-53.

Kincaid MC, Folberg R, Torczynski E, et al. Complications after proton beam therapy for uveal malignant melanoma. Ophthalmol 1988;95:982-91.

Saornil MA, Egan KM, Gragoudas ES, Seddon JM, Walsh SM, Albert DM. Histopathology of proton beam-irradiated vs. enucleated uveal melanomas. Arch Ophthalmol 1992;110:1112-8.

Young LHY, Gragoudas ES. Macular uveal melanoma treated with proton beam irradiation, 10 year follow-up observation with histopathologic correlation. Retina 1994;14:43-6.

Margo CE, Pautler SE. Granulomatous uveitis after treatment of a choroidal melanoma with proton beam irradiation. Retina 1990;10:150-3.

Guyer DR. Mukai S, Egan KM, Seddon JM, Walsh SM, Gragoudas ES. Radiation maculopathy after proton beam irradiation for choroidal melanoma. Ophthalmol 1992;99:1278-85.

Gragoudas ES, Egan KM, Arrigg, PG, Seddon JM, Glynn RJ, Munzenrider JE. Cataract extraction after proton beam irradiation for malignant melanoma of the eye. Arch Ophthalmol 1992;110:475-9.

Riedel KG, Svitra PP, Seddon JS, et al. Proton beam irradiation and hyperthermia, effects on experimental choroidal melanoma. Arch Ophthalmol 1985;103:1862-9.